# Rematiq

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rematiq

- Industry: Software
- Headquarters: Berlin, Germany
- Website: www.rematiq.com/
- Total disclosed funding: $6M
- Latest round: Seed (Sep 4, 2024)
- Investors on record: 4

## About

Rematiq GmbH provides innovative AI-driven product compliance solutions for Medtech firms, streamlining regulatory processes and enhancing operational efficiency.Rematiq GmbH, founded in 2023, specializes in AI-powered compliance solutions for the Medtech sector. The company is based in Berlin, Germany, with a focus on regulatory processes in research and development. The firm was established by individuals with previous entrepreneurial experience. Rematiq has completed one significant deal as part of its growth trajectory, securing EUR 5.4 million in Seed funding on April 10, 2025, with Project A Ventures leading the round alongside Amino Collective and HelloWorld.REMATIQ offers a comprehensive suite of AI-powered product compliance solutions designed to streamline regulatory processes for Medtech research and development teams. The core product is an intelligent compliance platform that automates the extraction and simplification of regulatory requirements from complex documents, linking them directly to their regulatory sources for end-to-end traceability. This product enables teams to convert lengthy, convoluted regulations into structured, usable data, thereby reducing the manual effort typically associated with compliance tasks. By eliminating document clutter and offering automated change processing, REMATIQ allows organizations to focus resources on innovation rather than regulatory burdens. The platform serves a diverse client base that includes Medtech companies across North America and Europe, supporting their efforts to maintain compliance while accelerating product development cycles.REMATIQ generates revenue through a subscription-based model, providing access to its compliance solutions to a range of clients including Medtech firms and other innovators operating in heavily regulated environments. The transactions typically involve annual subscriptions that grant organizations access to the platform’s features, including requirement extraction, automated change processing, and audit-ready reporting capabilities. Clients benefit from ongoing support and updates as part of their subscription, ensuring compliance with evolving regulatory landscapes. Specific pricing plans for these services are structured to accommodate the varying needs of clients, with options tailored for both small startups and larger enterprises, enhancing the flexibility of service delivery.In April 2025, Rematiq GmbH raised EUR 5.4 million in Seed funding led by Project A Ventures, with participation from Amino Collective and HelloWorld. The company will use the funding to develop its artificial intelligence technology and scale operations. Future growth plans include the design and launch of new products, expected to enhance compliance capabilities in the Medtech sector. Additionally, Rematiq aims to expand into new geographic markets, specifically targeting regions in North America and parts of Europe by mid-2026. These initiatives reflect a strategic focus on leveraging cutting-edge technology to improve compliance processes for its clients.

## Funding rounds

- Seed, Sep 4, 2024, $6M — Project A, Amino Collective, HelloWorld, Scout Fund Vii, Lp

## Investors

- Project A (https://capitalatlas.ai/funds/project-a) — Seed
- Amino Collective (https://capitalatlas.ai/funds/amino-collective) — Seed
- HelloWorld (https://capitalatlas.ai/funds/helloworld) — Seed
- Scout Fund Vii, Lp — Seed